FindTrial
Sign In

Effect of Madhugrit with Madhunashini Vati Extra Power in Type 2 Diabetes Mellitus

A Clinical Study to Evaluate the Antidiabetic Effect of Madhugrit with Madhunashini Vati Extra Power in Type 2 Diabetes Mellitus: Prospective, open label, single arm study - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/111873
Enrollment
136
Registered
2026-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil

Sponsors

Patanjali Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HbA1C between 5.8% to 8.5% The subject is able and willing to provide consent

Exclusion criteria

Exclusion criteria: Patients with Type 1 Diabetes Mellitus or on Insulin. Patients with Gestational diabetes. Patients with expected pregnancy or breastfeeding. Patients with uncontrolled HTN more than 140/90, Hepatic or renal failure.

Design outcomes

Primary

MeasureTime frame
Change in HbA1CTimepoint: Baseline to Day 90—

Secondary

MeasureTime frame
Change in the revised version of DQOL (RV-DQOL 13) questionnaireTimepoint: Baseline to Day 90—

Countries

India

Contacts

Public ContactDr Ajay Singh

Patanjali Ayurved Hospital

drajaysingh82@gmail.com9039402300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026